Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic assessment of disease activity in IBD. By merging data science with clinical expertise,
Some results have been hidden because they may be inaccessible to you
Show inaccessible results